Related Experiment Video
Updated: Jul 18, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Paediatric cerebral venous thrombosis
1Department of Pediatrics, Shcool of Medicine, Gaziantep University, Gaziantep, Turkey.
Insights
Cerebral venous thrombosis (CVT) in children is a serious, multifactorial condition increasingly diagnosed due to advanced imaging. Anticoagulant therapy, though debated, appears safe and beneficial for pediatric CVT, even with hemorrhages.
Area of Science:
- Pediatric Neurology
- Vascular Neurology
- Hematology
Background:
- Cerebral venous thrombosis (CVT) in children is a serious, multifactorial condition.
- Increasingly diagnosed due to enhanced imaging and clinical awareness.
- Manifestations can be severe, leading to neurological deficits.
Purpose of the Study:
- To review the diagnosis, risk factors, and treatment of pediatric CVT.
- To discuss the role of anticoagulation in pediatric CVT management.
Main Methods:
- Review of clinical presentations, diagnostic modalities, and treatment options for pediatric CVT.
- Analysis of the current evidence regarding anticoagulation in children with CVT.
Main Results:
- CVT presents variably and is associated with diverse risk factors like infection, dehydration, and hematological disorders.
- CT or MR venography are diagnostic standards; diffusion/perfusion MRI aid in assessing venous congestion.
- Anticoagulation with heparin is considered safe and potentially beneficial, even in cases with intracranial hemorrhage.
Conclusions:
- Pediatric CVT requires consideration in various acute neurological presentations.
- Anticoagulant therapy, typically with heparin followed by oral anticoagulants, is the established treatment approach.
- Evidence suggests heparin is safe and beneficial for pediatric CVT, including those with hemorrhages.
Abstract:
Cerebral venous thrombosis (CVT) in children is a multifactorial serious disease. It is being increasingly diagnosed, mainly because of more sensitive diagnostic procedures and increasing clinical awareness. The clinical manifestations can be life-threatening and cause long-term neurological deficits. Thromboembolism in children is a multifactorial disorder in which both genetic and acquired risk factors play a role. CVT occurs in various clinical settings, including infection, dehydration, renal failure, trauma, cancer and haematological disorder with multiple risk factors. Clinical manifestations of CSVT are nonspecific and may be subtle. Most of the clinical scenarios occur at all ages and the clinician should consider this diagnosis in a wide range of acute neurological presentations in childhood. CVT can have an extremely variable clinical presentation, mode of onset, imaging appearance and outcome. Its prognosis remains largely unpredictable. Diffusion and perfusion MRI may play a role in detecting venous congestion and CT or MR venography are now the methods of choice for investigation of cerebral venous thrombosis. The options for treatment of infants and children include standard or low molecular weight heparin for 7-10 days followed by oral anticoagulants for 3-6 months. Specific treatment with anticoagulation is controversial in children, but has been established as appropriate therapy in adults. Anticoagulant treatment with heparin is probably safe and beneficial for children with sinus thrombosis, even those with intracranial haemorrhages.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Cerebral Edema ll: Pathophysiology
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure l: Introduction